Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs
作者： E. Merisko‐Liversidge , P. Sarpotdar , J. Bruno , S. Hajj , L. Wei
关键词:
摘要: … containing drug and stabilizer was wet milled using preconditioned … stabilizer utilized, additional milling rendered finer particle dispersions. For this study, nanosuspensions were milled …
springer.com
sci-hub.se 参考文章(22)
O S Selawry, F M Muggia, M H Cohen, P J Creaven, H H Hansen, Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. Cancer chemotherapy reports. ,vol. 56, pp. 515- 521 ,(1972)
D. C. Tormey, K. D. Tutsch, J. K. V. Willson, Santhanam Swaminathan, K. J. Simon, J. L. Grem, D. B. Alberti, D. L. Trump, Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Cancer treatment reports. ,vol. 71, pp. 1179- 1184 ,(1987)
Susan E. Dunn, Anne Brindley, Stanley S. Davis, Martyn C. Davies, Lisbeth Illum, Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharmaceutical Research. ,vol. 11, pp. 1016- 1022 ,(1994) , 10.1023/A:1018939521589
D M Peereboom, R C Donehower, E A Eisenhauer, W P McGuire, N Onetto, J L Hubbard, M Piccart, L Gianni, E K Rowinsky, Successful re-treatment with taxol after major hypersensitivity reactions. Journal of Clinical Oncology. ,vol. 11, pp. 885- 890 ,(1993) , 10.1200/JCO.1993.11.5.885
M M Hudson, H J Weinstein, S S Donaldson, C Greenwald, L Kun, N J Tarbell, W A Humphrey, C Rupp, N M Marina, J Wilimas, Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. Journal of Clinical Oncology. ,vol. 11, pp. 1080- 1084 ,(1993) , 10.1200/JCO.1993.11.6.1080
P. Couvreur, L. Roblot-Treupel, M.F. Poupon, F. Brasseur, F. Puisieux, Nanoparticles as microcarriers for anticancer drugs Advanced Drug Delivery Reviews. ,vol. 5, pp. 209- 230 ,(1990) , 10.1016/0169-409X(90)90017-M
K. C. Nicolaou, C. Riemer, M. A. Kerr, D. R. Rideout, W. W. Wrasidlo, Design, synthesis and biological activity of protaxols. Nature. ,vol. 364, pp. 464- 466 ,(1993) , 10.1038/364464A0
STANLEY S. DAVIS, CLIVE WASHINGTON, PHILIP WEST, LISBETH ILLUM, GARRY LIVERSIDGE, LARRY STERNSON, RICHARD KIRSH, Lipid emulsions as drug delivery systems. Annals of the New York Academy of Sciences. ,vol. 507, pp. 75- 88 ,(1987) , 10.1111/J.1749-6632.1987.TB45793.X
John M Bennett, Gary H. Lymann, Peter A Cassileth, John H. Glick, Martin M. Oken, A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study. American Journal of Clinical Oncology. ,vol. 7, pp. 471- 474 ,(1984) , 10.1097/00000421-198410000-00015
R Gref, Y Minamitake, M. Peracchia, V Trubetskoy, V Torchilin, R Langer, Biodegradable long-circulating polymeric nanospheres Science. ,vol. 263, pp. 1600- 1603 ,(1994) , 10.1126/SCIENCE.8128245